Cargando…
Are anti-PD-1-associated immune related adverse events a harbinger of favorable clinical prognosis in patients with gastric cancer?
BACKGROUND: Immune checkpoint inhibitors (ICIs) has shown remarkable benefit in the treatment of a range of cancer types, although it may initiate immune related adverse events (irAEs) in patients. Some studies have shown that there is a close relationship between the occurrence of irAEs and prognos...
Autores principales: | Zhang, Xiaoyun, Xu, Shuo, Wang, Jiaqi, Lv, Yalei, Wang, Na, Lai, Ruixue, Sha, Ziyue, Zhao, Qun, Guo, Zhanjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636611/ https://www.ncbi.nlm.nih.gov/pubmed/36335320 http://dx.doi.org/10.1186/s12885-022-10199-x |
Ejemplares similares
-
Correlation Between Immune-Related Adverse Events and Prognosis in Hepatocellular Carcinoma Patients Treated With Immune Checkpoint Inhibitors
por: Xu, Shuo, et al.
Publicado: (2021) -
Dicer Enhances Bevacizumab-Related Inhibition of Hepatocellular Carcinoma via Blocking the Vascular Endothelial Growth Factor Pathway
por: Wang, Cuiju, et al.
Publicado: (2021) -
PHYSICAL HARBINGERS OF RELAPSE IN SCHIZOPHRENIA
por: Srinivasan, T.N., et al.
Publicado: (1994) -
Psychosis as Harbinger of Phenytoin Toxicity
por: Borasi, Manish, et al.
Publicado: (2015) -
Scleritis as the harbinger of Granulomatosis with polyangiitis
por: Kharel (Sitaula), Ranju, et al.
Publicado: (2022)